Types of deviation and review criteria in pretreatment central quality control of tumor bed boost in medulloblastoma—an analysis of the German Radiotherapy Quality Control Panel in the SIOP PNET5 MB trial

PURPOSE: In Germany, Austria, and Switzerland, pretreatment radiotherapy quality control (RT-QC) for tumor bed boost (TB) in non-metastatic medulloblastoma (MB) was not mandatory but was recommended for patients enrolled in the SIOP PNET5 MB trial between 2014 and 2018. This individual case review (...

Descripción completa

Detalles Bibliográficos
Autores principales: Dietzsch, Stefan, Braesigk, Annett, Seidel, Clemens, Remmele, Julia, Kitzing, Ralf, Schlender, Tina, Mynarek, Martin, Geismar, Dirk, Jablonska, Karolina, Schwarz, Rudolf, Pazos, Montserrat, Weber, Damien C., Frick, Silke, Gurtner, Kristin, Matuschek, Christiane, Harrabi, Semi Ben, Glück, Albrecht, Lewitzki, Victor, Dieckmann, Karin, Benesch, Martin, Gerber, Nicolas U., Obrecht, Denise, Rutkowski, Stefan, Timmermann, Beate, Kortmann, Rolf-Dieter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863746/
https://www.ncbi.nlm.nih.gov/pubmed/34351451
http://dx.doi.org/10.1007/s00066-021-01822-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8863746/
https://www.ncbi.nlm.nih.gov/pubmed/34351451
http://dx.doi.org/10.1007/s00066-021-01822-0

Ejemplares similares